Table II.
Univariate and Multivariate analysis of factors predicting worse overall
| Variable | Overall survival | |||
|---|---|---|---|---|
| Univariate | Multivariate | |||
| HR (95% CI) | P - value | HR (95% CI) | P - value | |
|
≥100 clonal cPCs
detected |
3.32 (2.05 - 5.41) | < 0.0001 | 2.67 (1.37 - 5.17) | 0.0041 |
|
Number of prior lines
of therapy |
1.15 (1.05 - 1.26) | 0.0027 | 4.09 (1.56 - 10.14) | 0.0048 |
| Serum creatinine | 1.56 (1.23 - 1.88) | 0.0008 | 1.29 (0.89 - 1.87) | 0.1723 |
| β2-microglobulin | 1.12 (1.07 – 1.16) | < 0.0001 | 1.05 (0.97 - 1.12) | 0.2165 |
|
Elevated LDH (> 222
u/l) |
1.02 (1.01 – 1.03) | < 0.0001 | 2.93 (1.67 - 5.08) | 0.0003 |
|
High bone marrow
PC% |
1.00 (0.99 - 1.02) | 0.0785 | - | - |
|
High risk status by
FISH |
1.64 (0.88 - 2.95) | 0.1138 | - | - |
survival
Bolded P-values and HRs represent statistically significant variables (i.e. P < 0.05)
cPCs, circulating plasma cells; LDH, lactate dehydrogenase; PC%, plasma cell percentage; FISH, fluorescent in-situ hybridization; HR, Hazard ratio; 95% CI, 95% confidence interval.